Cancer Genetics Acquires Gentris for $6,250,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ee28d752-4656-459b-b8e0-03c23fe1970c - Date
6/24/2014 - Company Name
Gentris - Mailing Address
133 Southcenter Court Morrisville, NC 27560 USA - Company Description
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions. - Website
http://www.gentris.com - Transaction Type
M&A - Transaction Amount
$6,250,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The purchase price is $3.25 million in cash, $1.5 million in Cancer Genetics stock, and performance-based earn outs up to $1.5 million, according to a news release.
